NeoGenomics at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
NeoGenomics brings 2 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 242. The cancer testing company presents on how triple-negative tumors evolve from early to metastatic stages and on real-world treatment, response and recurrence in early-stage disease.
| Organization | SABCS 2026 Attendance |
|---|---|
NeoGenomics Fort Myers, FL | |
Cancer diagnostics company running CLIA-certified labs that offer a broad oncology testing menu to oncologists, pathologists, hospitals and drug developers. | Booth Exhibiting at Booth 242 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 5–6:30pm |
Find decision makers at NeoGenomics
Tell us what you sell and we’ll find the people at NeoGenomics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction